EP3310362
Deoxýnúkleósíð meðferð fyrir sjúkdóma sem orsakast af vanstilltum kirnasöfnum þar með talið heilkenni hvatbera-DNA-þurrðar
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.6.2016EP published:
28.8.2019EP application number:
16812537.5
EP translation filed:
1.10.2019Grant published:
15.10.2019EPO information:
European Patent Register
Max expiry date:
16.6.2036Expiry date:
16.6.2026Next due date:
30.6.2026
Title:
DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES
Timeline
Today
17.6.2016EP application
28.8.2019EP Publication
1.10.2019Translation submitted
15.10.2019Registration published
16.6.2026Expires
Owner
Name:
The Trustees of Columbia University in the City of New YorkAddress:
412 Low Memorial Library 535 West 116th Street, 10027, New York, NY, US
Inventor
Name:
HIRANO, MichioAddress:
New York, NY, US
Name:
GARONE, CaterinaAddress:
Cambridge CB1 3 RE, GB
Name:
MARTI, RamonAddress:
Barcelona, ES
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562180914 PDate:
17.6.2015Country:
US
Classification
Categories:
A61K 31/7068, A61K 31/7064, A61K 31/7072, C07D 403/06, A61P 21/00, A61P 43/00, A61K 31/513, A61K 45/06, A61K 9/00, A61K 31/7076, A61K 31/708
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 23.6.2020
Expires: 16.6.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 24.6.2021
Expires: 16.6.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 28.6.2022
Expires: 16.6.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 24.5.2023
Expires: 16.6.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 11.6.2024
Expires: 16.6.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 10.6.2025
Expires: 16.6.2026
Payer: G.H. Sigurgeirsson ehf.